AssetMark Inc’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.16M Sell
36,704
-1,259
-3% -$39.7K ﹤0.01% 894
2025
Q1
$1.24M Buy
37,963
+4,748
+14% +$155K ﹤0.01% 827
2024
Q4
$1.2M Sell
33,215
-227
-0.7% -$8.21K ﹤0.01% 811
2024
Q3
$1.04M Buy
33,442
+908
+3% +$28.3K ﹤0.01% 773
2024
Q2
$870K Buy
32,534
+1,432
+5% +$38.3K ﹤0.01% 798
2024
Q1
$1.06M Buy
31,102
+1,403
+5% +$47.9K ﹤0.01% 718
2023
Q4
$859K Buy
29,699
+1,121
+4% +$32.4K ﹤0.01% 710
2023
Q3
$788K Buy
28,578
+629
+2% +$17.3K ﹤0.01% 660
2023
Q2
$840K Buy
27,949
+1,956
+8% +$58.8K ﹤0.01% 642
2023
Q1
$942K Buy
25,993
+1,423
+6% +$51.6K ﹤0.01% 611
2022
Q4
$876K Buy
24,570
+558
+2% +$19.9K ﹤0.01% 604
2022
Q3
$813K Buy
24,012
+22,107
+1,160% +$749K ﹤0.01% 560
2022
Q2
$55K Buy
1,905
+283
+17% +$8.17K ﹤0.01% 897
2022
Q1
$52K Sell
1,622
-15
-0.9% -$481 ﹤0.01% 912
2021
Q4
$48K Buy
1,637
+53
+3% +$1.55K ﹤0.01% 920
2021
Q3
$42K Buy
1,584
+15
+1% +$398 ﹤0.01% 816
2021
Q2
$48K Sell
1,569
-3
-0.2% -$92 ﹤0.01% 759
2021
Q1
$41K Buy
1,572
+81
+5% +$2.11K ﹤0.01% 757
2020
Q4
$38K Buy
1,491
+161
+12% +$4.1K ﹤0.01% 756
2020
Q3
$28K Buy
1,330
+420
+46% +$8.84K ﹤0.01% 773
2020
Q2
$22K Buy
910
+846
+1,322% +$20.5K ﹤0.01% 784
2020
Q1
$1K Sell
64
-22
-26% -$344 ﹤0.01% 1298
2019
Q4
$2K Buy
86
+8
+10% +$186 ﹤0.01% 1259
2019
Q3
$2K Buy
+78
New +$2K ﹤0.01% 1185
2018
Q1
Sell
-17
Closed -$1K 1949
2017
Q4
$1K Buy
+17
New +$1K ﹤0.01% 1712